EmslieGJ. The psychopharmacology of adolescent depression. J Child Adolesc Psychopharmacol, 22:2–4. 2012.
2.
KennardB, SilvaS, VitielloB, CurryJ, KratochvilC, SimonsA, HughesJ, FeenyN, WellerE, SweeneyM, ReineckeM, PathakS, GinsburgG, EmslieG, MarchJ. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS)J Am Acad Child Adolesc Psychiatry, 45:1404–1411. 2006.
3.
VitielloB, EmslieG, ClarkeG, WagnerKD, AsarnowJR, KellerMB, BirmaherB, RyanND, KennardB, MayesTL, DeBarL, LynchF, DickersonJ, StroberM, SuddathR, McCrackenJT, SpiritoA, OnoratoM, ZelaznyJ, PortaG, IyengarS, BrentDA. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: A follow-up study of the TORDIA sample. J Clin Psychiatry, 72:388–396. 2011.
4.
NuttD, GoodwinG. ECNP Summit on the future of CNS drug research in Europe 2011: Report prepared for ECNP by David Nutt and Guy Goodwin. Eur Neuropsychopharmacol, 21:495–499. 2011.
5.
SpiritoA, AbebeKZ, IyengarS, BrentD, VitielloB, ClarkeG, WagnerKD, AsarnowJ, EmslieG, KellerM. Sources of site differences in the efficacy of a multisite clinical trial: The Treatment of SSRI-Resistant Depression in Adolescents. J Consult Clin Psychol, 77:439–450. 2009.
6.
DeciccoJ, RossM. Recent advances in automotive technology and the cost-effectiveness of fuel economy improvement. Transportation Research Part D: Transport and Environment, 1:79–96. 1996.
7.
GilbertWS, SullivanA. The Mikado. 1885.
8.
NovarinoG, El-FishawyP, KayseriliH, MeguidNA, ScottEM, SchrothJ, SilhavyJL, KaraM, KhalilRO, Ben-OmranT, Ercan-SencicekAG, HashishAF, SandersSJ, GuptaAR, HashemHS, MaternD, GabrielS, SweetmanL, RahimiY, HarrisRA, StateMW, GleesonJG. Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science, 2012Sep6[Epub ahead of print].
9.
MaaloufFT, AtwiM, BrentDA. Treatment-resistant depression in adolescents: Review and updates on clinical management. Depress Anxiety, 28:946–954. 2011.
10.
LewisCC, SimonsAD, NguyenLJ, MurakamiJL, ReidMW, SilvaSG, MarchJS. Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS)J. Am Acad Child Adolesc Psychiatry, 49:132–140. 2010.
11.
ShamseddeenW, AsarnowJR, ClarkeG, VitielloB, WagnerKD, BirmaherB, KellerMB, EmslieG, IyengarS, RyanND, McCrackenJT, PortaG, MayesT, BrentDA. Impact of physical and sexual abuse on treatment response in the Treatment of Resistant Depression in Adolescent Study (TORDIA)J. Am Acad Child Adolesc Psychiatry, 50:293–301. 2011.
12.
OrruG, Pettersson-YeoW, MarquandAF, SartoriG, MechelliA. Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review. Neurosci Biobehav Rev, 36:1140–1152. 2012.
13.
HanM, DaiJ, ZhangY, LinQ, JiangM, XuX, LiuQ, JiaJ. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer. Oncol Rep., 2012.
14.
EloyanA, MuschelliJ, NebelMB, LiuH, HanF, ZhaoT, BarberAD, JoelS, PekarJJ, MostofskySH, CaffoB. Automated diagnoses of attention deficit hyperactive disorder using magnetic resonance imaging. Front Syst Neurosci, 6:61. 2012.
